Labo'Life
CompanySpain
Labo'Life develops one asset, in phase 3 (2LALERG in seasonal allergy). Mostly other acting on inflammation; based in Spain.
- 1
- Asset
- Furthest stage
- Phase 3
- 1
- Trial
- 1
- Signal
Pipeline
1Micro-immunotherapy formulation modulating allergic and inflammatory immune responses
Phase 3, Other, Inflammation, seasonal allergy
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials1
- Signals1
- Similar companies6